The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of neodjuvant chemoimmunotherapy followed by stereotactic radiotherapy/nelfinavir in patients with locally advanced CA125 expressing pancreatic adenocarcinoma.
 
Chi Lin
Research Funding - BioMimetix; Quest PharmaTech
 
Quan P. Ly
No Relationships to Disclose
 
Lyudmyla Derby Berim
No Relationships to Disclose
 
James K. Schwarz
No Relationships to Disclose
 
Madi Madiyalakan
Employment - Oncobiologics
Leadership - Oncobiologics
Stock and Other Ownership Interests - Oncobiologics
Honoraria - Oncobiologics
Consulting or Advisory Role - Oncobiologics
Patents, Royalties, Other Intellectual Property - OncoQuest
Travel, Accommodations, Expenses - Oncobiologics
Other Relationship - Oncobiologics
 
Christopher F. Nicodemus
Leadership - Hemispherx Biopharma; OncoVent
Stock and Other Ownership Interests - Hemispherx Biopharma; OncoQuest
Consulting or Advisory Role - Hemispherx Biopharma; OncoQuest
Patents, Royalties, Other Intellectual Property - Onco Quest
 
Michael A. Hollingsworth
Stock and Other Ownership Interests - Sangamo Bioscience
Research Funding - Glycomimetics (Inst)
Patents, Royalties, Other Intellectual Property - Royalties on Cell lines (Inst)
 
Jane L Meza
No Relationships to Disclose
 
Chandrakanth Are
Research Funding - Pfizer
 
James Padussis
No Relationships to Disclose
 
Jean L. Grem
No Relationships to Disclose